secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2025-12-12T23:59:59+00:00
Accession:  0001628280-25-056659
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio launches $6.7M public offering of common stock and warrants
-------------------------------------------------------------------

- Offering comprises 2.6M shares, 8.1M pre-funded warrants ($0.0001/share), and 10.7M Series F warrants ($0.75/share) at $0.75 per unit.
- Net proceeds expected ~$6.7M; funds working capital, product development, and general corporate purposes.
- Closing anticipated December 12, 2025; H.C. Wainwright acts as placement agent with 7.0% cash fee plus warrants.
- Company believes proceeds plus existing cash will fund operations into Q4 2026; 60-day lockup on further equity issuance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000162828025056659/0001628280-25-056659-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000162828025056659/val-20251211.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-056659

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer